← Back to Search

Behavioral Intervention

Virtual Reality for Public Speaking Anxiety (ETC2 Trial)

N/A
Waitlist Available
Led By Michael Otto, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment assessment immediately after the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine whether people's general level of positivity or their temporary mood affects how well exposure therapy works for speech anxiety. The study will also look at how feelings of self-confidence, hope,

Who is the study for?
This trial is for individuals with anxiety disorders, specifically those who experience speech anxiety or social anxiety disorder. Participants should be comfortable using virtual reality (VR) technology as the intervention involves a single-session VR exposure.
What is being tested?
The study tests if a one-time virtual reality session can help reduce speech anxiety. It also explores whether long-term personality traits or temporary emotional states better predict how well people will respond to this VR therapy.
What are the potential side effects?
Since the intervention uses VR, side effects may include temporary discomfort like dizziness, nausea, or headaches due to the immersive nature of VR. Psychological side effects could involve increased anxiety during or after exposure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week follow-up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week follow-up assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Assessed using the Social Phobia Inventory (SPIN)
Public Speaking Anxiety
Valence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Positive or Negative Mood Induction via film clipsExperimental Treatment1 Intervention
VR exposure is the only intervention, but the VR intervention is conducted following either positive or negative mood induction.

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
120 Previous Clinical Trials
12,527 Total Patients Enrolled
1 Trials studying Public Speaking
48 Patients Enrolled for Public Speaking
The University of Hong KongOTHER
1,194 Previous Clinical Trials
1,326,863 Total Patients Enrolled
University of Texas at AustinOTHER
374 Previous Clinical Trials
85,335 Total Patients Enrolled
~560 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top